Amedica Corp. (NASDAQ:AMDA) has been given a $5.00 target price by research analysts at Maxim Group in a research note issued on Thursday. The brokerage presently has a “buy” rating on the stock.

Shares of Amedica Corp. (NASDAQ:AMDA) opened at 0.7118 on Thursday. The company has a 50 day moving average of $0.77 and a 200-day moving average of $0.98. The company’s market cap is $18.79 million. Amedica Corp. has a 12-month low of $0.60 and a 12-month high of $3.62.

COPYRIGHT VIOLATION WARNING: This article was first posted by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are viewing this article on another domain, it was illegally copied and republished in violation of U.S. & international trademark & copyright legislation. The original version of this article can be read at

Amedica Corp. Company Profile

Amedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer. It is focused on using its silicon nitride ceramic technology platform to develop, manufacture and sell a range of medical devices. It is also engaged in developing wear- and corrosion-resistant implant components for hip and knee arthroplasty.

5 Day Chart for NASDAQ:AMDA

Receive News & Stock Ratings for Amedica Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedica Corp. and related stocks with our FREE daily email newsletter.